Tienoven, D.T. van

bcar 1 patient cancer bcar 1 levels level breast tumor status protein analysis menopausal status breast cancer model base model prognostic nodal status menopausal prognostic value postmenopausal nodal prognosis value urokinase-type plasminogen activator postmenopausal patients ͻ0.0001 interaction factor treatment table premenopausal subgroups disease plasminogen multivariate hazard activator adjuvant breast tumor cytosols bcar 1 protein breast cancer patients bcar 1 status point ratio cytosol base models 130ca cell migration tissue research elisa association metastasi survival assay univariate result addition postmenopausal /node patients analyses premenopausal /node patients likelihood ratio test van putten wlj therapy premenopausal patients 2593 patients /node bcar 1/p function marker grade prognostic factors breast tumors correlation ⌬␹2 receptor migration difference rotterdam interval expression